The Well Biotech COVID-19 Ag Rapid Saliva Test Device uses double antibody sandwich immunoassay. The NC membrane pre-immobilized with monoclonal antibodies against SARS-CoV-2 antigen and anti-mouse polyclonal antibodies, and the colloidal-gold conjugated with monoclonal antibodies specific to SARS-CoV-2 antigen. If SARS-CoV-2 antigen present in the sample, a complex formed between the anti-SARS-CoV-2 conjugate and the antigen will be caught by the specific anti- SARS-CoV-2 monoclonal coated on the T region. Results appear in 10 to 20 minutes in the form of a red line that develops on the strip. Whether the sample contains the SARS-CoV-2 antigen or not, the solution continues to migrate to encounter another reagent (an anti-mouse IgG antibody) that binds the remaining conjugates, thereby producing a red line on the region C.
- Test time: 15 minutes
- Sensitivity: 91%
- Specificity: 99%
- Sample type: Saliva
The Orawell COVID-19 Ag Rapid saliva test device (Self-test) is manufactured and approved for use by the Therapeutic Goods Administration (TGA) .
Buy the Orawell COVID-19 Ag Rapid saliva test device (Self-test) for Detecting SARS-CoV-2 for Your WorkPlace
If your company or organisation is interested in rapid testing solutions, contact us today for help procuring the Orawell COVID-19 Ag Rapid saliva test device (Self-test) for Detecting SARS-CoV-2 for detecting SARS-CoV-2 or other rapid tests authorised by the Therapeutic Goods Administration (TGA) .
If you’re interested in rapid testing solutions, contact us today for a quote. You can also place an order for the Orawell COVID-19 Ag Rapid saliva test device (Self-test) for Detecting SARS-CoV-2 or other rapid tests approved by the TGA.
Our team at Rapid Tests Australia can also assist with implementing a rapid testing program to protect your workplace from the risks of COVID-19.